Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: Development and validation of a brief instrument

European Addiction Research

Volumn 20, Issue 1, 2013, Pages 41-48

  Mestre Pintó, Joan Ignasi ^a   Domingo Salvany, Antònia ^a,b   Martín Santos, Rocío ^a,b,c   Torrens, Marta ^a,d,e  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Dual diagnosis; Dual Diagnosis Screening Instrument; Psychopathology; Screening

Indexed keywords

ADULT; AGORAPHOBIA; ARTICLE; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DSM-IV-TR; DUAL DIAGNOSIS SCREENING INSTRUMENT; FEMALE; GENERALIZED ANXIETY DISORDER; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; OUTPATIENT; PANIC; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHIATRIC RESEARCH INTERVIEW FOR SUBSTANCE AND MENTAL DISORDER; PSYCHOMETRY; PSYCHOSIS; SENSITIVITY AND SPECIFICITY; SOCIAL PHOBIA; SUBSTANCE USE; TEST RETEST RELIABILITY; UNIVERSITY HOSPITAL;

ADULT; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); DRUG USERS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MENTAL DISORDERS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84880973404     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000351519     Document Type: Article

References (35)

1. Kranzler HR, Rounsaville BJ: Dual Diagnosis and Psychiatric Treatment: Substance Abuse and Comorbid Disorders, ed 2. New York, Dekker, 2004.
2. Brady KT, Verduin ML, Tolliver BK: Treatment of patients comorbid for addiction and other psychiatric disorders. Curr Psychiatry Rep 2007; 9: 374-380.
3. Pierucci-Lagha A, Gelernter J, Feinn R, Cubells JF, Pearson D, Pollastri A, Farrer L, Kranzler HR: Diagnostic reliability of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA). Drug Alcohol Depend 2005; 80: 303-312.
4. Torrens M, Serrano D, Astals M, Perez-Dominguez G, Martin-Santos R: Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. Am J Psychiatry 2004; 161: 1231-1237.
5. Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R: Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry 2006; 163: 689-696.
6. Morgello S, Holzer CE III, Ryan E, Young C, Naseer M, Castellon SA, Frol AB, Atkinson JH, Gelman BB, Grant I, Singer EJ: Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium. Int J Methods Psychiatr Res 2006; 15: 131-138.
7. Torrens M, Rossi PC, Martinez-Riera R, Martinez-Sanvisens D, Bulbena A: Psychiatric comorbidity and substance use disorders: treatment in parallel systems or in one integrated system? Subst Use Misuse 2012; 47: 1005-1014.
8. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20):22-33.
9. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV III, Hahn SR, Brody D, Johnson JG: Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 Study. JAMA 1994; 272: 1749-1756.
10. Broadhead WE, Leon AC, Weissman MM, Barrett JE, Blacklow RS, Gilbert TT, Keller MB, Olfson M, Higgins ES: Development and validation of the SDDS-PC screen for multiple mental disorders in primary care. Arch Fam Med 1995; 4: 211-219.
11. Zimmerman M, Sheeran T, Chelminski I, Young D: Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders. J Subst Abuse Treat 2004; 26: 181-188.
12. Perez GB, Garcia FL, de Vicente Manzanaro MP, Oliveras Valenzuela MA: Validation of the Psychiatric Diagnostic Screening Questionnaire (PDSQ) in a Spanish sample of alcoholic patients (in Spanish). Adicciones 2010; 22: 199-205.
13. Castel S, Rush B, Kennedy S, Fulton K, Toneatto T: Screening for mental health problems among patients with substance use disorders: preliminary findings on the validation of a self-assessment instrument. Can J Psychiatry 2007; 52: 22-27.
14. Magruder KM, Sonne SC, Brady KT, Quello S, Martin RH: Screening for co-occurring mental disorders in drug treatment populations. J Drug Issues 2005; 35: 593-605.
15. Lincoln AK, Liebschutz JM, Chernoff M, Nguyen D, Amaro H: Brief screening for cooccurring disorders among women entering substance abuse treatment. Subst Abuse Treat Prev Policy 2006; 1: 26.
16. Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIMEMD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 282: 1737-1744.
17. Delgadillo J, Payne S, Gilbody S, Godfrey C, Gore S, Jessop D, Dale V: How reliable is depression screening in alcohol and drug users? A validation of brief and ultra-brief questionnaires. J Affect Disord 2011; 134: 266-271.
18. Carroll JFX, McGinley JJ: A screening form for identifying mental health problems in alcohol/ other drug-dependent persons. Alcohol Treat Quart 2001; 19: 33-47.
19. Sacks S, Melnick G, Coen C, Banks S, Friedmann PD, Grella C, Knight K, Zlotnick C: CJDATS Co-Occurring Disorders Screening Instrument (CODSI) for Mental Disorders (MD): a validation study. Crim Justice Behav 2007; 34: 1198-1216.
20. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WA: Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; 420 :8-20.
21. Torrens M, Martin-Santos R, Samet S: Importance of clinical diagnoses for comorbidity studies in substance use disorders. Neurotox Res 2006; 10: 253-261.
22. Cuenca-Royo AM, Sanchez-Niubo A, Forero CG, Torrens M, Suelves JM, Domingo-Salvany A: Psychometric properties of the CAST and SDS scales in young adult cannabis users. Addict Behav 2012; 37: 709-715.
23. Gilchrist G, Blazquez A, Torrens M: Psychiatric, behavioural and social risk factors for HIV infection among female drug users. AIDS Behav 2011; 15: 1834-1843.
24. Herrero MJ, Domingo-Salvany A, Torrens M, Brugal MT: Psychiatric comorbidity in young cocaine users: induced versus independent disorders. Addiction 2008; 103: 284-293.
25. Martin-Santos R, Torrens M, Poudevida S, Langohr K, Cuyas E, Pacifici R, Farre M, Pichini S, de la Torre R: 5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study. Addict Biol 2010; 15: 15-22.
26. Yubero-Lahoz S, Pardo R, Farre M, O'Mahony B, Torrens M, Mustata C, Perez-Mana C, Carbo ML, de la Torre R: Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans. Clin Pharmacokinet 2011; 50: 319-329.
27. Torrens M, Gilchrist G, Domingo-Salvany A: Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders. Drug Alcohol Depend 2011; 113: 147-156.
28. Ramos-Quiroga JA, Diaz-Digon L, Comin M, Bosch R, Palomar G, Chalita JP, Roncero C, Nogueira M, Torrens M, Casas M: Criteria and Concurrent Validity of Adult ADHD Section of the Psychiatry Research Interview for Substance and Mental Disorders. J Atten Disord 2013 (E-pub ahead of print).
29. Fleiss JL, Levin BA, Paik MC: Statistical Methods for Rates and Proportions, ed 3. New York, Wiley, 2003.
30. Fein G, Di Sclafani V, Finn P, Scheiner DL: Subdiagnostic psychiatric comorbidity in alcoholics. Drug Alcohol Depend 2007; 87: 139-145.
31. Pani PP, Maremmani I, Trogu E, Gessa GL, Ruiz P, Akiskal HS: Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included? J Affect Disord 2010; 122: 185-197.
32. Van den Bosch LM, Verheul R: Patients with addiction and personality disorder: Treatment outcomes and clinical implications. Curr Opin Psychiatry 2007; 20: 67-71.
33. Fenton MC, Keyes K, Geier T, Greenstein E, Skodol A, Krueger B, Grant BF, Hasin DS: Psychiatric comorbidity and the persistence of drug use disorders in the United States. Addiction 2012; 107: 599-609.
34. Dakwar E, Nunes EV, Bisaga A, Carpenter KC, Mariani JP, Sullivan MA, Raby WN, Levin FR: A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. Am J Addict 2011; 20: 441-446.
35. Samet S, Fenton MC, Nunes E, Greenstein E, Aharonovich E, Hasin D: Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence. Addiction 2013; 108: 115-123.